|Podcasts|November 3, 2011

CER and Personalized Medicine: Insights from the Experts

CER and Personalized Medicine: Insights from the Experts

Kathy Wyrwich, Senior Research Leader, Outcomes Research, United BioSource, shares insights on comparative effectiveness research and personalized medicine with discussions she had with stakeholders from Pfizer, Duke University School of Medicine and Medco Research Institute.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast
May 2nd 2025
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development
January 6th 2023
The Evolving Relationship Between Sponsors and the Contract Research Organizations
December 8th 2022
The MDR: Navigating Europe’s New Standard for Medical Device Safety
October 25th 2022
The impact an eClinical Supply Chain Management platform can have on your next clinical trial
September 19th 2022

Trending on Applied Clinical Trials Online

Latest NIMBLE Study Results Highlight Progress in gMG Research

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

© 2025 MJH Life Sciences^®

All rights reserved.